A medical electrical lead having a conductor assembly covered by an insulating layer, and a shield covering positioned adjacent or proximate to at least a portion of the insulating layer in order to shield the conductor assembly from one or more electromagnetic fields. The shield covering is formed of a polymer-matrix composite. The polymer-matrix composite includes a polymeric resin having discontinuous conductive fillers provided therein. The discontinuous conductive fillers include one or more of nano-sized metal structures and nano-sized non-metallic conductive structures. The nano-sized non-metallic conductive structures can have a coating formed of one or more metals. The nano-sized non-metallic conductive structures can be formed of carbon. In turn, the nano-sized non-metallic conductive structures can include one or more of carbon nanofibers, carbon filaments, carbon nanotubes, and carbon nanoflakes.
|
1. An apparatus for alleviating the adverse effects of various health ailments of a patient comprising:
a medical device; and
an electrical lead connected to the medical device at a proximal end of the lead and having at least a distal end, the distal end of the electrical lead having one or more electrodes or electrical contacts for sensing and/or therapy delivery, the electrical lead comprising a conductor assembly having one or more conductors covered by an insulating layer and the electrical lead further comprising a shield covering adjacent in a radial direction or proximate in the radial direction to at least a portion of the insulating layer to shield the conductors from one or more electromagnetic fields, the shield covering comprising a polymer-matrix composite, the polymer-matrix composite including a polymeric resin having discontinuous conductive fillers provided therein, the discontinuous conductive fillers comprising nano-sized non-metallic conductive structures, the discontinuous conductive fillers being gradiently distributed radially at least within a continuous portion of the polymer-matrix composite with a greater concentration at the surface of the shield covering and being uniformly distributed circumferentially and longitudinally at the surface of the polymer-matrix, the shield covering being circumferentially and longitudinally continuous over an entire length of the shield covering.
|
The present invention relates generally to medical devices, and, more particularly, to reducing the effects of electromagnetic radiation on such medical devices.
Since their earliest inception, implantable medical devices (IMDs) have continually been advanced in significant ways. Today, IMDs include therapeutic and diagnostic devices, such as pacemakers, cardioverter/defibrillators, hemodynamic monitors, neurostimulators, and drug administering devices, as well as other devices for alleviating the adverse effects of various health ailments.
As is known, modern electrical therapeutic and diagnostic devices for the heart and other areas of the body generally include an electrical connection between the device and the body. This connection is usually provided by at least one medical electrical lead. For example, a neurostimulator delivers mild electrical impulses to neural tissue using one or more electrical leads. In turn, such neurostimulation often results in effective pain relief and a reduction in the use of pain medications and/or repeat surgeries. Each electrical lead used with such devices typically takes the form of a long, generally straight, flexible, insulated conductor. At its proximal end, the lead is typically connected to a connector of the device, which also may be implanted within the patient's body. Generally, one or more electrodes are located at or near the distal end of the lead and are attached to, or otherwise come in contact with, the body. Such devices may be controlled by a physician or a patient through the use of an external programmer.
It is well known that, if not shielded sufficiently, the implanted leads of medical devices can be adversely affected when a patient is exposed to alternating electromagnetic fields. Alternating electromagnetic fields can generally stem from any of a number of radio-frequency radiation sources, e.g., magnetic resonance imaging (MRI) systems as described below. As such, if an implanted medical lead is not sufficiently shielded, electromagnetic fields can induce an electric current within a conductor of the lead. In turn, such an implanted electrical lead would act as an antenna, resulting in an electrical current that flows from the electrode of the lead and through body tissue. Because the tissue area associated with electrode contact may be very small, the current densities may be high, which can result in tissue heating that may cause damage.
There can be other limitations associated with exposing implanted leads of medical devices to electromagnetic fields and/or radio-frequency energy if the leads are not sufficiently shielded therefrom. As is known, a sudden burst of radio-frequency energy can cause an electric pulse within the lead. The medical device, as should be appreciated, can sense the imposed voltage on the lead, and in turn, may cause the device to respond inappropriately, resulting in the wrong therapy being administered to the patient at that time or in the future. For example, with respect to cardiac IMDs, inappropriate therapy modification may be one response of the IMD, which can involve changing the rate or thresholds associated with pacing pulses.
As is known, magnetic resonance imaging (MRI) is an anatomical imaging tool which utilizes non-ionizing radiation (i.e., no x-rays or gamma rays) and provides a non-invasive method for the examination of internal structure and function. For example, MRI permits the study of the overall function of the heart in three dimensions significantly better than any other imaging method. Furthermore, MRI scanning is widely used in the diagnosis of diseases and injuries to the head. Magnetic resonance spectroscopic imaging (MRSI) systems are also known and are herein intended to be included within the terminology “MRI” systems or scanners. These MRI systems can be used to give valuable diagnostic information, but also subject the patient to significant alternating electromagnetic fields and/or radio-frequency energy, which may result in one or more of the undesirable effects described above with respect to IMDs or medical devices using implanted leads.
A variety of different coverings have been used for implantable leads of medical devices to overcome the above limitations. Some coverings have involved metal or metal alloy wire being braided around the lead, thereby forming a shield having a large conductive surface area. Other coverings have involved the use of polymer-matrix composites. Such composite coverings, as opposed to metal wire coverings, are attractive due to their moldability. In addition, the composite coverings are more favorable because metal wire coverings can be prone to damage by scratching, abrasion, or wear.
Polymer-matrix composite coverings are conductive due to the presence therein of electrically conducting fillers, which can be discontinuous (e.g., such as particles or short fibers) or continuous (e.g., such as continuous fibers). As is known, even though they lack the continuity provided by continuous fillers, discontinuous fillers can just as well be used for electromagnetic shielding. Moreover, discontinuous fillers are suitable for composite fabrication by extrusion or injection molding and, if the discontinuous filler is fine enough in size, even by ink-jet printing or screen printing. Due to the lower cost and greater versatility of composite fabrication for discontinuous fillers compared to continuous fillers, discontinuous fillers have been widely used in making electrically conducting composites, especially those for electromagnetic shielding.
While polymer-matrix composites having discontinuous fillers have been used as lead coverings to reduce the effects of electromagnetic radiation, they have been found to present certain limitations, e.g., with respect to their overall shielding effectiveness. What is needed is apparatus used to reduce the potential adverse effects to medical devices, and in particular, to implantable electrical leads of the devices, when subjected to electromagnetic radiation, while further overcoming one or more of the limitations facing the discontinuous filler polymer-matrix composite lead coverings marketed to date.
Embodiments of the invention relate to a medical electrical lead having a conductor assembly covered by an insulating layer, and a shield covering positioned adjacent or proximate to at least a portion of the insulating layer in order to shield the conductor assembly from one or more electromagnetic fields. The shield covering is formed of a polymer-matrix composite. The polymer-matrix composite includes a polymeric resin having discontinuous conductive fillers provided therein. The discontinuous conductive fillers include one or more of nano-sized metal structures and nano-sized non-metallic conductive structures. The nano-sized non-metallic conductive structures can have a coating formed of one or more metals. The nano-sized non-metallic conductive structures can be formed of carbon. In turn, the nano-sized non-metallic conductive structures can include one or more of carbon nanofibers, carbon filaments, carbon nanotubes, and carbon nanoflakes.
The following detailed description should be read with reference to the drawings, in which like elements in different drawings are numbered identically. The drawings depict selected embodiments and are not intended to limit the scope of the invention. It will be understood that embodiments shown in the drawings and described below are merely for illustrative purposes, and are not intended to limit the scope of the invention as defined in the claims.
Embodiments of the invention relate to medical devices, and specifically relate to shield coverings for leads extending between the devices and the patient. Embodiments described and illustrated herein pertain to implantable medical devices (IMDs); however, the invention can extend to any lead-bearing medical device, whether implantable or not. Furthermore, while the embodiments provided herein relate to certain IMDs, it should be appreciated that such embodiments are exemplary in nature. As such, the invention is not limited to any particular IMD, but instead is applicable to any IMD, including therapeutic and diagnostic devices, such as pacemakers, cardioverter/defibrillators, hemodynamic monitors, neurostimulators, and drug administering devices, as well as other devices for alleviating the adverse effects of various health ailments.
The neurostimulator 12 may be considered to be an implantable pulse generator and capable of generating multiple pulses occurring either simultaneously or one pulse shifting in time with respect to the other, and having independently varying amplitudes and pulse widths. The neurostimulator 12 contains a power source and electronics for sending precise, electrical pulses to the spinal cord 22 to provide the desired treatment therapy. While the neurostimulator 12 typically provides electrical stimulation by way of pulses, other forms of stimulation may be used such as continuous electrical stimulation.
The lead 16 includes one or more insulated electrical conductors each coupled at their proximal end to a connector 24 and to the electrodes 18 (or contacts) at its distal end. As is known, some leads are designed to be inserted into a patient percutaneously and some are designed to be surgically implanted. In certain embodiments, the lead 16 may contain a paddle at its distant end for housing the electrodes 18. In alternate embodiments, the electrodes 20 may comprise one or more ring contacts at the distal end of the lead 16.
While the lead 16 is shown as being implanted in position to stimulate a specific site in the spinal cord 22, it could also be positioned along the peripheral nerve or adjacent neural tissue ganglia or may be positioned to stimulate muscle tissue. Furthermore, electrodes 18 (or contacts) may be epidural, intrathecal or placed into spinal cord 22 itself. Effective spinal cord stimulation may be achieved by any of these lead placements. While the lead connector at proximal end of the lead 16 may be coupled directly to the neurostimulator 12, the lead connector is typically coupled to the lead extension 14 as is shown in
Implantable leads of IMDs similar to those described above in
One material that can be used when forming discontinuous fillers for use in polymer-matrix composites is carbon; however, the invention should not be limited to such. Instead, any other conductive material demonstrating similar advantageous properties, as described herein with respect to carbon, may be alternatively used. When provided in a discontinuous form, carbon can be presented in a wide variety of structures, including particulates, powders, fibers, filaments, flakes, and the like. In general, such structures are commercially available and practical to produce in sizes typically on the order of micrometers. For example, carbon filaments/fibers can be provided having outer diameters ranging in size from about 0.1 μm to about 12 μm. As should be appreciated, these diameter sizes are significantly reduced from the diameter sizes of commercially available metal wire (e.g., typically having minimum outer diameters of about 20 μm). As a result, such discontinuous carbon fillers are found to be less susceptible to the skin effect at high frequencies as compared to discontinuous metal wire fillers, as described below.
In general, when a static electrical field is applied to a conductor, the mobile charges therein, e.g., the electrons, are found to move and create a direct current (DC), which is uniformly distributed on the entire cross section of the conductor, resulting in a uniform current density. However, when an electromagnetic field is imposed on such a conductor, the mobile charges therein are found to oscillate back and forth with the same frequency as the impinging fields. The movement of these charges constitutes an alternating current (AC). Due to the attenuation of the electromagnetic waves in the conductor, the conductor's current density is greatest at the conductor's surface and declines exponentially as a function of depth. The decline in current density versus depth is known as the skin effect, and the skin depth is a measure of the distance over which the current falls from its value at the conductor's surface.
As shown, carbon is also limited due to the skin effect, but to a lesser extent than the metals. However, as described above, carbon fiber can be made having a smaller diameter than metal wire. As a result, a larger cross-sectional area of the carbon fiber can be used for conductive purposes in comparison to conventionally available metal wire. Therefore, carbon fiber can be found to be more efficient than metal wire, in particular, when used as a shield in the presence of high frequency electromagnetic fields. For example, as demonstrated in
As is known, for a polymer-matrix composite, the electromagnetic radiation shielding effectiveness increases with increasing filler volume fraction in the composite. However, the maximum filler volume fraction is limited by the poor composite mechanical properties at high filler volume fractions resulting from the poor filler-matrix bonding. As described above, discontinuous carbon can generally be preferable to discontinuous metal wire because a higher percentage of the cross-sectional area of the carbon can be used for conductivity purposes, particularly in the presence of high frequency electromagnetic fields. Though, even with this increased efficiency, the usable cross-sectional area of the carbon is generally found to be less conductive than metal wire. However, because the carbon, e.g., carbon fiber, is smaller in diameter than metal wire, a greater quantity of such carbon can be utilized in the matrix material. In turn, the increased efficiency of the carbon (as described above with respect to skin depth) with the greater quantity of carbon in the matrix material enables the carbon to collectively exhibit enhanced conductivity throughout the composite. As such, using micro-sized carbon in polymer-matrix composites provides a more effective shield as a lead covering in the presence of electromagnetic fields as opposed to metal wire.
Further, when fillers are provided that are conductive yet smaller in size than their alternatives, as is the case in the above example comparing micro-sized carbon and metal wire, the matrix material of the composite can also be reduced while still maintaining the warranted volume fractions of the composite. As a result, a thinner lead covering can be provided that is more effective at shielding the electrical lead. Further, provided the micro-sized carbon and other alternative filler material are comparable in price, materials and process savings can be realized by using micro-sized carbon while still providing good mechanical properties for the composite.
While the above embodiment demonstrates higher electromagnetic radiation shielding effectiveness being achieved when using micro-sized carbon instead of metal wire as discontinuous fillers in polymer-matrix composites, even higher shielding effectiveness can be achieved in such composites. As described above, carbon structures can be made discontinuous so as to have sizes on the order of micrometers. However, carbon structures can also be further reduced in size on the order of nanometers. Examples of such carbon structures include nanofibers, filaments, nanotubes, and nanoflakes. Alternatively, certain metals can be formed into nano-sized structures, e.g., particles and/or flakes, which would also be more effective as fillers in comparison to discontinuous wire or micro-sized carbon structures. Such fillers can include but are not limited to Ag, Au, Cu, Co, Ni, Pt, Sn, Ta, Ti, Zn, or any alloys thereof.
Accordingly, in certain embodiments, a polymer-matrix composite is provided having discontinuous fillers, with the fillers including one or more of nano-sized non-metallic conductive structures and nano-sized metal structures. The use of the term “structures” herein with respect to “nano-sized non-metallic conductive structures” and “nano-sized metal structures” is meant to indicate “one or more different structures” in making up the fillers in each case. In certain embodiments, as described above, the nano-sized non-metallic conductive structures can be formed of carbon. In turn, in certain embodiments, the nano-sized non-metallic conductive structures can include one or more of carbon nanofibers, carbon filaments, carbon nanotubes, and carbon nanoflakes. For example, carbon nanofibers are widely available from a number of commercial sources, one being Pyrograf Products, Inc., an affiliate of Applied Sciences, Inc., located in Cedarville, Ohio. One such carbon nanofiber provided by Pyrograf Products, Inc. is the Pyrograf®-III, ranging in diameter from about 70 and about 200 nanometers. In many cases, carbon nanofiber is commercially available ranging in diameter from about 70 to about 500 nanometers. The nano-sized metal structures can be introduced to the composite using commercially available nano-sized metal particles or by means of in-situ reduction of desired metal ions injected into the matrix via chemical method, metal ion implantation method, or other suitable methods.
As should be appreciated, similar to that already described above in comparing discontinuous fillers of conventional carbon structures and metal wire, when nano-sized carbon and/or nano-sized metal are used instead of the conventional micro-sized carbon and/or metals in forming the fillers, the resulting composites would have enhanced electromagnetic shielding effectiveness. As such, discontinuous fillers formed of nano-sized carbon structures and/or nano-sized metal structures, because of their reduced size (as compared to conventional micro-sized carbon and/or metals of same volume fraction), would be less susceptible to skin effect at high frequencies. Further, because of their reduced size, the discontinuous fillers formed of nano-sized carbon structures and/or nano-sized metal structures can be provided in increased quantity in the matrix material compared to micro-sized carbon fiber structures and discontinuous metal wire.
In some cases, nano-sized carbon structures may be selected over nano-sized metal structures. One reason may be due to cost considerations. However, as should be appreciated, using nano-sized carbon structures in polymer-matrix composites can be costly as compared to using conventional micro-sized carbon structures. One way to address this is to select the least costly of the carbon nano-sized structures. As is known, carbon nanofibers and carbon nanoflakes are less expensive to produce than carbon nanotubes. For example, material cost to produce one pound of Pyrograf®-III carbon nanofibers is less than $50, while producing the same amount of single walled carbon nanotubes, e.g., from CarboLex, Inc., located in Lexington, Ky., is about $16,030. As such, in terms of cost considerations, carbon nanofiber is generally preferred over carbon nanotubes.
Further advantages in using carbon nanofiber are illustrated with respect to
One challenge encountered to date in using nano-sized carbon structures as discontinuous fillers in polymer-matrix composites is their natural tendency to clump together. As such, effective dispersion of the nano-sized carbon structures throughout the matrix material can be difficult, which in turn, can compromise the shielding effectiveness of such composites. For example, if a quantity of carbon nanofibers is selected based on a uniform distribution throughout the matrix material, if the fibers clump, this uniform distribution would be difficult to achieve. In turn, the shielding effectiveness would likely not be uniformly dispersed through the composite, leaving some areas more susceptible to penetration by electromagnetic radiation.
It has been found through experimentation that this clumping phenomenon of nano-sized carbon structures can be overcome. Specifically, by providing a thin coating of metal on the nano-sized carbon structures prior to their disbursement in matrix material when forming polymer-matrix composites, one can offset the natural tendency of the nano-sized carbon structures to clump together. As a result, uniform shielding effectiveness for the composite can be achieved using nano-sized carbon structures, e.g., carbon nanofibers, which have a tendency to clump together. As such, in certain embodiments, carbon nanofibers, carbon filaments, carbon nanotubes, and carbon nanoflakes used as fillers can be provided with a metal coating. Such metal coating, in certain embodiments, can be provided so as to be no greater than about 1 μm. Metalization of carbon nanofibers, carbon filaments, carbon nanotubes, and carbon nanoflakes can be achieved via physical vapor deposition, chemical vapor deposition, auto-catalytic electroless deposition, or other metallization techniques known to the art. The metal coating can include but are not limited to Ag, Au, Cu, Co, Ni, Pt, Sn, Ta, Ti, Zn, alloys thereof, as well as any combination thereof.
It should be appreciated that such metal coating also enhances the conductivity, and thus, shielding effectiveness, of the carbon structures. For example, the metal coating can be made of nickel.
As shown, the lead/extension 70 has a shield covering 74, which functions to shield electromagnetic radiation from the lead conductors. In certain embodiments, the shield covering 74 is provided as a polymer-matrix composite. As described herein, the polymer-matrix composite generally includes a polymeric resin 76 having conductive fillers provided therein. As shown, in certain embodiments, the conductive fillers are discontinuous conductive fillers. The discontinuous conductive fillers, in certain embodiments, can be nano-sized non-metallic conductive structures 78, nano-sized metal structures 80, or the combination of both (as exemplarily shown in
As described above, in certain embodiments, the nano-sized non-metallic conductive structures 78 can be formed of carbon. The carbon structures, in certain embodiments, can include one or more of carbon nanofibers, carbon filaments, carbon nanotubes, and carbon nanoflakes. As should be appreciated, when the nano-sized carbon structures are selected, one would need to select the particular grade for the structures. For example, as is known, there are many grades of carbon fibers commercially available. As such, one would select the grade which has or is able to be produced to have a desirable diameter dimension, yet also exhibits low electrical resistivity and high strength properties. In certain embodiments, the fillers have an outer diameter ranging in size from about 70 nanometers to about 500 nanometers.
As further shown, in certain embodiments, the nano-sized non-metallic conductive structures 78 are each coated with a metal coating 82, including but not limited to Ag, Au, Cu, Co, Ni, Pt, Sn, Ta, Ti, Zn, alloys thereof, as well as any combination thereof. As such, the nano-sized non-metallic conductive structures 78 can be prevented from clumping so as to be uniformly disbursed in the resin 76 and the conductivity of the fillers can be enhanced. The covering 74 is not in direct electrical contact with the conductors of the conductor assembly of the lead/extension 70. In certain embodiments, the covering 74 can be in contact with the housing of the medical device (e.g., IMD) from which they stem, where the device can act as an additional surface for dissipation of energy received by the covering 74 from electromagnetic radiation.
It should be appreciated that the lead/extension 70 can be either a lead, an extension for a lead, or both. For example, with respect to the IMD 10 of
The amount of the discontinuous fillers, or combinations of fillers formed of different materials, to be incorporated into the matrix material can vary depending on the desired properties exhibited by the particular medical device or medical device component. As described above, enough of the discontinuous fillers should be included so that desired properties are at least minimally exhibited by the composite, but not so much of the fillers should be included so as to have a detrimental effect on the properties of the composite. While the particular range may vary depending on the filler and matrix materials being utilized, composites exhibiting advantageous properties can be obtained by incorporating from about 0.005% to about 99% filler material relative of the total final composition weight of the composite. In many embodiments, filler material may be incorporated in an amount of from about 0.01% up to about 40% or 50% by weight of the composite. In a typical embodiment, the filler material can be incorporated in an amount of from about 0.1% to about 20% of the composite, for example, from about 1% to about 10% by weight of the composite.
Each of
In certain embodiments, the lead/extension 120 of
It will be appreciated the embodiments of the present invention can take many forms. The true essence and spirit of these embodiments of the invention are defined in the appended claims, and it is not intended the embodiment of the invention presented herein should limit the scope thereof.
Li, Bernard, Cai, Chad, Chen, Xingfu
Patent | Priority | Assignee | Title |
10035014, | Apr 30 2009 | Medtronic, Inc | Steering an implantable medical lead via a rotational coupling to a stylet |
10086194, | Apr 30 2009 | Medtronic, Inc | Termination of a shield within an implantable medical lead |
10155111, | Jul 24 2014 | Medtronic, Inc | Methods of shielding implantable medical leads and implantable medical lead extensions |
10186350, | Jul 26 2016 | General Cable Technologies Corporation | Cable having shielding tape with conductive shielding segments |
10260968, | Mar 15 2013 | NANO COMPOSITE PRODUCTS, INC | Polymeric foam deformation gauge |
10263174, | Mar 15 2013 | NANO COMPOSITE PRODUCTS, INC | Composite material used as a strain gauge |
10279171, | Jul 23 2014 | Medtronic, Inc. | Methods of shielding implantable medical leads and implantable medical lead extensions |
10398893, | Feb 14 2007 | Medtronic, Inc. | Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding |
10405779, | Jan 07 2015 | NANO COMPOSITE PRODUCTS, INC | Shoe-based analysis system |
10517198, | Jun 14 2018 | General Cable Technologies Corporation | Cable having shielding tape with conductive shielding segments |
10658567, | Mar 15 2013 | Nano Composite Products, Inc. | Composite material used as a strain gauge |
11329212, | Mar 15 2013 | Nano Composite Products, Inc. | Composite conductive foam insole |
11424048, | Jun 28 2018 | CARLISLE INTERCONNECT TECHNOLOGIES, INC | Coaxial cable utilizing plated carbon nanotube elements and method of manufacturing same |
11564594, | Jan 07 2015 | Nano Composite Products, Inc. | Shoe-based analysis system |
11874184, | Mar 15 2013 | Nano Composite Products, Inc. | Composite conductive foam |
9186499, | Apr 30 2009 | Medtronic, Inc | Grounding of a shield within an implantable medical lead |
9205253, | Apr 30 2009 | Medtronic, Inc | Shielding an implantable medical lead |
9216286, | Apr 30 2009 | Medtronic, Inc | Shielded implantable medical lead with guarded termination |
9220893, | Apr 30 2009 | Medtronic, Inc. | Shielded implantable medical lead with reduced torsional stiffness |
9259572, | Apr 25 2007 | Medtronic, Inc. | Lead or lead extension having a conductive body and conductive body contact |
9272136, | Apr 30 2009 | Medtronic, Inc. | Grounding of a shield within an implantable medical lead |
9302101, | Mar 30 2004 | Medtronic, Inc. | MRI-safe implantable lead |
9452284, | Apr 30 2009 | Medtronic, Inc. | Termination of a shield within an implantable medical lead |
9463317, | Apr 19 2012 | Medtronic, Inc. | Paired medical lead bodies with braided conductive shields having different physical parameter values |
9629998, | Apr 30 2009 | Medtronics, Inc. | Establishing continuity between a shield within an implantable medical lead and a shield within an implantable lead extension |
9731119, | Mar 12 2008 | Medtronic, Inc. | System and method for implantable medical device lead shielding |
9857246, | Sep 17 2014 | SENSABLE TECHNOLOGIES, LLC | Sensing system including a sensing membrane |
9993638, | Dec 14 2013 | Medtronic, Inc. | Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead |
Patent | Priority | Assignee | Title |
3788329, | |||
3915174, | |||
4038990, | Nov 19 1975 | Medtronic, Inc. | Cautery protection circuit for a heart pacemaker |
4220813, | Sep 26 1977 | PACIFIC COAST TECHNOLOGIES, INC , A WA CORP | Terminal for medical instrument |
4280507, | Jun 27 1979 | Koninklijke Philips Electronics N V | Patient cable with distributed resistance protection in conductors |
4320763, | Oct 10 1979 | Pacesetter, Inc | Protection device for pacemaker implantees |
4383225, | Jul 06 1979 | SOCIETE D APPLICATION DES FERRITES MUSORB, SOCIETE ANONYME, THE | Cables with high immunity to electro-magnetic pulses (EMP) |
4628942, | Oct 11 1984 | Case Western Reserve University | Asymmetric shielded two electrode cuff |
4711027, | Dec 15 1983 | Pacesetter, Inc | Implantable lead construction |
4726379, | Nov 14 1985 | CARDIAC CONTROL SYSTEMS, INC , A CORP OF DE | Cardiac pacer with switching circuit for isolation |
4852585, | Aug 08 1980 | KIMBERLY-CLARK WORKDWIDE, INC | Tin-stannous chloride electrode element |
4920980, | Sep 14 1987 | Cordis Corporation | Catheter with controllable tip |
4947866, | Feb 16 1988 | Medtronic, Inc. | Medical electrical lead |
4951672, | Jul 02 1985 | General Electric Company | Controlled impedance monitoring lead wires |
4991583, | Aug 13 1986 | Pacesetter, Inc | Pacemaker having independently programmable electrode configuration for pacing and sensing and method for operation thereof |
5012045, | Mar 03 1988 | Sumitomo Electric Industries, Ltd. | Cable with an overall shield |
5018523, | Apr 23 1990 | Cardiac Pacemakers, Inc. | Apparatus for common mode stimulation with bipolar sensing |
5020544, | Nov 01 1989 | Cardiac Pacemakers, Inc | Low energy defibrillation electrode |
5020545, | Jan 23 1990 | Pacesetter, Inc | Cardiac lead assembly and method of attaching a cardiac lead assembly |
5036862, | Apr 06 1987 | Cordis Corporation | Implantable, self-retaining lead |
5040544, | Feb 16 1988 | Medtronic, Inc. | Medical electrical lead and method of manufacture |
5063932, | Oct 03 1989 | MIROWSKI FAMILY VENTURES L L C | Controlled discharge defibrillation electrode |
5197468, | Sep 18 1990 | Device for protecting an electronic prosthesis from adverse effects of RF and/or electrostatic energy | |
5217010, | May 28 1991 | The Johns Hopkins University | ECG amplifier and cardiac pacemaker for use during magnetic resonance imaging |
5246438, | Nov 25 1988 | INNOVATIVE CARDIAC SOLUTIONS, INC | Method of radiofrequency ablation |
5260128, | Dec 11 1989 | Kabushiki Kaisha Riken | Electromagnetic shielding sheet |
5271417, | Jan 23 1990 | Cardiac Pacemakers, Inc. | Defibrillation electrode having smooth current distribution |
5314459, | Jan 23 1990 | Cardiac Pacemakers, Inc. | Defibrillation electrode system having smooth current distribution with floating electrode |
5323776, | Oct 15 1992 | Picker International, Inc. | MRI compatible pulse oximetry system |
5335657, | May 03 1991 | LivaNova USA, Inc | Therapeutic treatment of sleep disorder by nerve stimulation |
5349133, | Oct 19 1992 | ROGERS, WESLEY A | Magnetic and electric field shield |
5366496, | Apr 01 1993 | Cardiac Pacemakers, Inc. | Subcutaneous shunted coil electrode |
5370644, | Nov 25 1988 | INNOVATIVE CARDIAC SOLUTIONS, INC | Radiofrequency ablation catheter |
5374778, | Nov 02 1992 | Sumitomo Wiring Systems, Ltd. | Wire harness |
5417719, | Aug 25 1993 | WILES, TERRY L | Method of using a spinal cord stimulation lead |
5458629, | Feb 18 1994 | Medtronic, Inc. | Implantable lead ring electrode and method of making |
5466252, | Oct 02 1992 | W L GORE & ASSOCIATES, INC | Implantable lead |
5476496, | Jun 01 1993 | Pacesetter AB | Implantable medical electrode system having an indifferent electrode formed as a part of the electrode insulator sleeve |
5504274, | Sep 20 1994 | United Technologies Corporation | Lightweight braided shielding for wiring harnesses |
5514172, | Aug 31 1994 | Pacesetter, Inc.; SIEMENS PACESETTER, INC | Multi-conductor lead including a connector with an interlocking insulator |
5515848, | Oct 22 1991 | ADVANCED NEUROMODULATION SYSTEMS, INC | Implantable microelectrode |
5523578, | Mar 22 1995 | Electromagnetic radiation shielding arrangement and method for radiation therapy patients | |
5527348, | Feb 03 1995 | Medtronic, Inc | Magnetically permeable E-shield and method of connection thereto |
5591218, | Aug 09 1994 | ELA Medical | Current limiter for implantable electronic device lead |
5594304, | Jul 31 1995 | Woodhead Industries, Inc. | Portable fluorescent lamp for use in special applications |
5609622, | Feb 01 1993 | W L GORE & ASSOCIATES, INC | Implantable electrode with conductive polytetrafluoroethylene elecrode |
5629622, | Jul 11 1995 | Koninklijke Philips Electronics N V | Magnetic field sense system for the protection of connected electronic devices |
5649965, | Dec 30 1994 | Sorin CRM SAS | Protection against electromagnetic perturbations of external origin for a active implantable device |
5662697, | Oct 17 1995 | Pacesetter, Inc.; Pacesetter, Inc | Transvenous internal cardiac defibrillation apparatus having lead and electrode providing even distribution of electrical charge |
5676694, | Jun 07 1996 | Medtronic, Inc | Medical electrical lead |
5683435, | Nov 13 1995 | Pacesetter, Inc. | Implantable medical device having shielded and filtered feedthrough assembly and methods for making such assembly |
5697909, | May 10 1994 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
5697958, | Jun 07 1995 | SULZER INTERMEDICS INC | Electromagnetic noise detector for implantable medical devices |
5702437, | Apr 10 1996 | Medtronic Inc. | Implantable lead with wires carried by body |
5722998, | Jun 07 1995 | Intermedics, Inc. | Apparatus and method for the control of an implantable medical device |
5727552, | Jan 11 1996 | Medtronic, Inc. | Catheter and electrical lead location system |
5751539, | Apr 30 1996 | GREATBATCH, LTD NEW YORK CORPORATION | EMI filter for human implantable heart defibrillators and pacemakers |
5782241, | Apr 22 1993 | Schiller Medical | Sensor device for electrocardiogram |
5814076, | Feb 09 1996 | SIRROM CAPITAL CORPORATION | Apparatus for improved cardiac pacing and sensing using extracardiac indifferent electrode configurations |
5827997, | Sep 30 1994 | Metal filaments for electromagnetic interference shielding | |
5830136, | Oct 31 1996 | Nellcor Puritan Bennett Incorporated | Gel pad optical sensor |
5842966, | May 04 1990 | BIO-MAGNESTIC FIELD THERAPY SYSTEMS INC | Treatment of arthritis with magnetic field therapy |
5851226, | Oct 22 1996 | Medtronic, Inc | Temporary transvenous endocardial lead |
5905627, | Sep 10 1997 | GREATBATCH, LTD NEW YORK CORPORATION | Internally grounded feedthrough filter capacitor |
5927345, | Apr 30 1996 | Target Therapeutics, Inc | Super-elastic alloy braid structure |
5954760, | May 07 1997 | Pacesetter AB | Helical winding for a cardiac lead |
5964705, | Aug 22 1997 | Image-Guided Drug Delivery System, Inc. | MR-compatible medical devices |
5970429, | Aug 08 1997 | AVAGO TECHNOLOGIES GENERAL IP SINGAPORE PTE LTD | Method and apparatus for measuring electrical noise in devices |
6033408, | Jul 30 1996 | MIDAS REX, L P | Resecting tool for magnetic field environment |
6055457, | Mar 13 1998 | Medtronic, Inc. | Single pass A-V lead with active fixation device |
6101417, | May 12 1998 | Pacesetter, Inc.; Pacesetter, Inc | Implantable electrical device incorporating a magnetoresistive magnetic field sensor |
6195267, | Jun 23 1999 | CLUSTER, LLC; Optis Wireless Technology, LLC | Gel structure for combined EMI shielding and thermal control of microelectronic assemblies |
6198972, | Apr 30 1997 | Medtronic, Inc. | Control of externally induced current in implantable medical devices |
6209764, | Apr 30 1997 | Medtronic, Inc. | Control of externally induced current in implantable medical devices |
6258071, | Aug 31 1995 | Magnetic resonance-compatible needle | |
6265466, | Feb 12 1999 | EIKOS INC | Electromagnetic shielding composite comprising nanotubes |
6284971, | Nov 25 1998 | Johns Hopkins University | Enhanced safety coaxial cables |
6302740, | Apr 18 1996 | Interconnect AB | Shielded cable and connector assembly |
6348070, | Apr 17 1998 | MED-EL ELEKTROMEDIZINISCHE GERATE GES M B H | Magnetic-interference-free surgical prostheses |
6424234, | Sep 18 1998 | GREATBATCH, LTD NEW YORK CORPORATION | ELECTROMAGNETIC INTERFERENCE (EMI) FILTER AND PROCESS FOR PROVIDING ELECTROMAGNETIC COMPATIBILITY OF AN ELECTRONIC DEVICE WHILE IN THE PRESENCE OF AN ELECTROMAGNETIC EMITTER OPERATING AT THE SAME FREQUENCY |
6471699, | Oct 15 1993 | EP Technologies, Inc. | Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements |
6488704, | May 07 2001 | Biomed Solutions, LLC | Implantable particle measuring apparatus |
6494916, | Jul 30 2001 | Biomed Solutions, LLC | Apparatus for replacing musculo-skeletal parts |
6501991, | Jun 21 2000 | Medtronic, Inc. | Electrically-isolated multiple conductor lead body |
6503648, | Mar 26 2001 | Biomed Solutions, LLC | Implantable fuel cell |
6506972, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Magnetically shielded conductor |
6529774, | Nov 09 2000 | NeuroPace, Inc | Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation |
6538191, | Sep 26 2001 | Biomed Solutions, LLC | Photocell with fluorescent conversion layer |
6606521, | Jul 09 2001 | NeuroPace, Inc. | Implantable medical lead |
6640137, | Mar 15 2002 | Biomed Solutions, LLC | Biothermal power source for implantable devices |
6660116, | Mar 01 2000 | Medtronic, Inc | Capacitive filtered feedthrough array for an implantable medical device |
6671544, | Jun 28 2001 | Medtronic, Inc | Low impedance implantable extension for a neurological electrical stimulator |
6675033, | Apr 15 1999 | LANDMARK COMMUNITY BANK | Magnetic resonance imaging guidewire probe |
6695761, | Jan 30 2002 | ELECTROHEALING HOLDINGS, INC | Apparatus for assisting a heart |
6708051, | Nov 10 1998 | Compumedics Limited | FMRI compatible electrode and electrode placement techniques |
6711440, | Apr 11 2002 | BIOPHAN TECHNOLOGIES, INC | MRI-compatible medical device with passive generation of optical sensing signals |
6712844, | Jun 06 2001 | Advanced Cardiovascular Systems, Inc. | MRI compatible stent |
6713671, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Magnetically shielded assembly |
6718203, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6718207, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6725092, | Apr 25 2002 | Biophan Technologies, Inc. | Electromagnetic radiation immune medical assist device adapter |
6735471, | Apr 30 1996 | Medtronic, Inc | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
6741892, | Mar 10 2000 | Boston Scientific Neuromodulation Corporation | Movable contact locking mechanism for spinal cord stimulator lead connector |
6750055, | Mar 07 2001 | ELECTROHEALING HOLDINGS, INC | Implantable artificial organ and physiological monitoring system |
6757566, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6760628, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6763268, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6765144, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Magnetic resonance imaging coated assembly |
6768053, | Jan 09 2002 | BIOPHAN TECHNOLOGIES, INC | Optical fiber assembly |
6778856, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6792316, | Oct 08 1999 | ADVANCED NEUROMODULATION SYSTEMS, INC | Cardiac implant cable having a coaxial lead |
6793642, | May 07 2001 | Biomed Solutions, LLC | Flow cytometer |
6795730, | Apr 20 2000 | Medtronic, Inc | MRI-resistant implantable device |
6795736, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6799067, | Dec 26 2001 | Advanced Cardiovascular Systems, INC | MRI compatible guide wire |
6799069, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6815609, | Dec 18 2002 | BIOPHAN TECHNOLOGIES, INC | Nanomagnetic composition |
6819954, | Feb 20 2001 | Medtronic, Inc | Electromagnetic interference immune tissue invasive system |
6819958, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6844492, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Magnetically shielded conductor |
6845259, | Dec 26 2001 | Advanced Cardiovascular Systems, Inc. | MRI compatible guide wire |
6845267, | Sep 28 2000 | Boston Scientific Neuromodulation Corporation | Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation |
6850805, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6852091, | Aug 12 1992 | Medtronic Vidamed, Inc. | Medical probe device and method |
6864418, | Dec 18 2002 | BIOPHAN TECHNOLOGIES, INC | Nanomagnetically shielded substrate |
6869683, | May 07 2001 | Shin-Etsu Chemical Co., Ltd. | Electromagnetic wave absorber |
6871091, | Oct 31 2001 | Medtronic, Inc | Apparatus and method for shunting induced currents in an electrical lead |
6872882, | Jul 16 2001 | GENTHERM GMBH | Areal electric conductor comprising a constriction |
6875180, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
6879861, | Dec 21 2000 | Medtronic, Inc | Polymeric materials with improved dielectric breakdown strength |
6882519, | Mar 31 2003 | RUBYCON CORPORATION | Flat aluminum electrolytic capacitor and method of manufacturing the same |
6895280, | Jul 27 1999 | Boston Scientific Neuromodulation Corporation | Rechargeable spinal cord stimulator system |
6901290, | Feb 20 2001 | Medtronic, Inc | Electromagnetic interference immune tissue invasive system |
6906256, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Nanomagnetic shielding assembly |
6920361, | Feb 14 2003 | Medtronic, Inc. | Reverse wound electrodes |
6922590, | Nov 21 2000 | Boston Scientific Neuromodulation Corporation | Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion |
6925328, | Apr 20 2000 | Medtronic, Inc | MRI-compatible implantable device |
6930242, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Magnetically shielded conductor |
6937906, | Jan 29 2002 | Medtronic, Inc | Method and apparatus for detecting static magnetic fields |
6944489, | Oct 31 2001 | Medtronic, Inc | Method and apparatus for shunting induced currents in an electrical lead |
6949929, | Jun 24 2003 | Medtronic, Inc | Magnetic resonance imaging interference immune device |
6954674, | Feb 20 2001 | Medtronic, Inc | Electromagnetic interference immune tissue invasive system |
6968236, | Jan 28 2002 | BIOPHAN TECHNOLOGIES, INC | Ceramic cardiac electrodes |
6971391, | Dec 18 2002 | BIOPHAN TECHNOLOGIES, INC | Protective assembly |
6980865, | Jan 22 2002 | BIOPHAN TECHNOLOGIES, INC | Implantable shielded medical device |
6982378, | Mar 07 2003 | Hewlett-Packard Development Company, L.P. | Lossy coating for reducing electromagnetic emissions |
6985775, | Jan 29 2002 | Medtronic, Inc | Method and apparatus for shunting induced currents in an electrical lead |
6993387, | Feb 20 2001 | Medtronic, Inc | Electromagnetic interference immune tissue invasive system |
6999818, | May 23 2003 | GREATBATCH, LTD NEW YORK CORPORATION | Inductor capacitor EMI filter for human implant applications |
6999821, | Jan 18 2002 | Pacesetter, Inc.; Pacesetter, Inc | Body implantable lead including one or more conductive polymer electrodes and methods for fabricating same |
7013174, | Feb 20 2001 | BIOPHAN TECHNOLOGIES, INC | Electromagnetic interference immune tissue invasive system |
7013180, | Jan 29 2002 | METRONIC, INC | Conditioning of coupled electromagnetic signals on a lead |
7015393, | Apr 02 2003 | Medtronic, Inc | Device and method for preventing magnetic-resonance imaging induced damage |
7050855, | Jan 29 2002 | Medtronic, Inc | Medical implantable system for reducing magnetic resonance effects |
7076283, | Oct 31 2001 | Medtronic, Inc | Device for sensing cardiac activity in an implantable medical device in the presence of magnetic resonance imaging interference |
7082328, | Jan 29 2002 | Medtronic, Inc | Methods and apparatus for controlling a pacing system in the presence of EMI |
7103413, | Jul 12 2002 | Cardiac Pacemakers, Inc | Ferrite core telemetry coil for implantable medical device |
7123013, | Jun 24 2003 | Medtronic, Inc | Magnetic resonance imaging interference immune device |
7233825, | Feb 15 2003 | Medtronic, Inc. | Impedance measurement in implanted device |
7257449, | May 30 2001 | Cardiac Pacemakers, Inc | Extendable/retractable lead having downsized lead body |
7292894, | Sep 27 2002 | Medtronic, Inc | Methods and apparatus for joining small diameter conductors within medical electrical leads |
7319901, | Mar 31 2005 | Medtronic, Inc | Optional telemetry antenna for implantable medical devices |
7363090, | Apr 13 2001 | Greatbatch Ltd. | Band stop filter employing a capacitor and an inductor tank circuit to enhance MRI compatibility of active implantable medical devices |
7389148, | May 05 2004 | Pacesetter, Inc.; Pacesetter, Inc | Electrode design for defibrillation and/or sensing capabilities |
20020116028, | |||
20020116029, | |||
20020116033, | |||
20020116034, | |||
20020133202, | |||
20020138110, | |||
20020183438, | |||
20030093107, | |||
20030109901, | |||
20030117787, | |||
20030120197, | |||
20030144718, | |||
20030144719, | |||
20030144720, | |||
20030204217, | |||
20030225331, | |||
20040020674, | |||
20040028859, | |||
20040068307, | |||
20040071949, | |||
20040199069, | |||
20040249428, | |||
20040263174, | |||
20050065587, | |||
20050070972, | |||
20050080471, | |||
20050113876, | |||
20050159661, | |||
20050182471, | |||
20050222642, | |||
20050222647, | |||
20050222656, | |||
20050222657, | |||
20050222658, | |||
20050222659, | |||
20060155270, | |||
20060200218, | |||
20060247747, | |||
20060247748, | |||
20070106332, | |||
20070185556, | |||
20080033497, | |||
20080039709, | |||
20080195186, | |||
20080269863, | |||
EP624383, | |||
EP713714, | |||
EP760196, | |||
EP1273922, | |||
EP1424095, | |||
EP1466576, | |||
JP11086641, | |||
JP7255863, | |||
WO180940, | |||
WO3061755, | |||
WO3063952, | |||
WO2005102447, | |||
WO27279, | |||
WO180940, | |||
WO2083236, | |||
WO3037429, | |||
WO3063946, | |||
WO3063948, | |||
WO3063953, | |||
WO3063954, | |||
WO3063955, | |||
WO3063956, | |||
WO3063957, | |||
WO3075797, | |||
WO3092326, | |||
WO3095022, | |||
WO2004052448, | |||
WO2004073040, | |||
WO2005030322, | |||
WO2005102444, | |||
WO2005102445, | |||
WO2005102446, | |||
WO2006031317, | |||
WO2006093685, | |||
WO2006093686, | |||
WO2006118640, | |||
WO2006118641, | |||
WO2008100839, | |||
WO2008100840, | |||
WO2008134196, | |||
WO9628951, | |||
WO9741923, | |||
WO9910035, | |||
WO9919020, | |||
WO9960370, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 14 2007 | Medtronic, Inc. | (assignment on the face of the patent) | / | |||
Apr 04 2007 | LI, BERNARD | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019168 | /0906 | |
Apr 04 2007 | CHEN, XINGFU | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019168 | /0906 | |
Apr 04 2007 | LI, BERNARD | Medtronic, Inc | CORRECTIVE ASSIGNMENT TO CORRECT THE TITLE PREVIOUSLY RECORDED ON REEL 019168 FRAME 0906 ASSIGNOR S HEREBY CONFIRMS THE THE ASSIGNMENT OF ASSIGNOR S INTEREST | 019198 | /0793 | |
Apr 04 2007 | CHEN, XINGFU | Medtronic, Inc | CORRECTIVE ASSIGNMENT TO CORRECT THE TITLE PREVIOUSLY RECORDED ON REEL 019168 FRAME 0906 ASSIGNOR S HEREBY CONFIRMS THE THE ASSIGNMENT OF ASSIGNOR S INTEREST | 019198 | /0793 | |
Apr 12 2007 | CAI, CHAD | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 019168 | /0906 | |
Apr 12 2007 | CAI, CHAD | Medtronic, Inc | CORRECTIVE ASSIGNMENT TO CORRECT THE TITLE PREVIOUSLY RECORDED ON REEL 019168 FRAME 0906 ASSIGNOR S HEREBY CONFIRMS THE THE ASSIGNMENT OF ASSIGNOR S INTEREST | 019198 | /0793 |
Date | Maintenance Fee Events |
Nov 21 2018 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Nov 16 2022 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Jun 02 2018 | 4 years fee payment window open |
Dec 02 2018 | 6 months grace period start (w surcharge) |
Jun 02 2019 | patent expiry (for year 4) |
Jun 02 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 02 2022 | 8 years fee payment window open |
Dec 02 2022 | 6 months grace period start (w surcharge) |
Jun 02 2023 | patent expiry (for year 8) |
Jun 02 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 02 2026 | 12 years fee payment window open |
Dec 02 2026 | 6 months grace period start (w surcharge) |
Jun 02 2027 | patent expiry (for year 12) |
Jun 02 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |